1. Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations

   • José L. Górriz
   • Irene Romera
   • Juan F. Merino-Torres

   Review Open access 17 February 2022 Pages: 389 - 421

   

2. Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2 Diabetes

   • Chinmay Dwibedi
   • Birgitta Abrahamsson
   • Anders H. Rosengren

   Original Research Open access 12 February 2022 Pages: 423 - 439

   

3. Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus

   • Werimo Pascal Kuka
   • Jasmit Shah
   • Dilraj Singh Sokhi

   Original Research Open access 14 February 2022 Pages: 441 - 451

   

4. Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study

   • Dragana Nikolic
   • Angelo M. Patti
   • Manfredi Rizzo

   Original Research Open access 15 February 2022 Pages: 453 - 464

   

5. Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin

   • Jieling Chen
   • Sujana Borra
   • Robert C. Hood

   Original Research Open access 21 February 2022 Pages: 465 - 479

   

6. Cystic Fibrosis-Related Diabetes Mellitus and Pregnancy: A Retrospective Study

   • Recie Davern
   • Gabriela Balan
   • Mensud Hatunic

   Original Research Open access 21 February 2022 Pages: 481 - 487

7. The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark

   • Lars H. Ehlers
   • Mark Lamotte
   • Niels Ejskjaer

   Original Research Open access 21 February 2022 Pages: 489 - 503

   

8. Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

   • Adrian Heald
   • Mike Stedman
   • Martin Whyte

   Original Research Open access 21 February 2022 Pages: 505 - 516

   

9. Conversations and Reactions Around Severe Hypoglycemia (CRASH): Japan Results From a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers

   • Toshiyuki Iwahori
   • Frank Snoek
   • Mark Peyrot

   Original Research Open access 24 February 2022 Pages: 517 - 533

   

10. Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition

    • Medha N. Munshi
    • Sarah L. Sy
    • Darren M. Triller

    Original Research Open access 28 February 2022 Pages: 535 - 549

11. Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria

    • Chiara Di Loreto
    • Viviana Minarelli
    • Paola Del Sindaco

    Original Research Open access 01 March 2022 Pages: 551 - 567

    

12. Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study

    • Rayaz A. Malik
    • Tarik Elhadd
    • Mohamed Hassanein

    Original Research Open access 03 March 2022 Pages: 569 - 581